Treatment-resistant depression and the T-rex combination
The T-Rex combination of Trintellix (vortioxetine) and Rexulti (brexpiprazole) targets multiple neurotransmitter systems, providing a novel and effective approach for managing treatment-resistant depression. This article is available to American Nurses Association members and ANJ subscribers only. Already a member? Log…